Preclinical Capabilities Atlantic Bone Screen offers end-to-end preclinical evaluation services for inflammation, osteoarticular and skin diseases, with in vitro, in vivo, histology, imaging and tissue analysis capabilities, presenting a one-stop-shop for early drug candidates and biomaterial assessment.

Bone and Orthopedics Focus Specialization in bone-related research and applications for orthopedic and dental biomaterials positions the company as a preferred CRO for clients developing osteoporosis treatments, arthritis therapies, bone cancer studies and related nutraceuticals.

In-House Animal Models Own rodent facilities and validated animal models for human bone pathologies enable faster project timelines and potential cost efficiencies, appealing to sponsors seeking reliable preclinical data and scalable study options.

Biomaterials & Cosmetics Capability to evaluate biomaterials and ingredients for cosmetics and food products expands market reach beyond pharmaceuticals, offering diversification opportunities for clients with multi-industry needs.

Growth via Partnerships Sister company AtlAnthera in bone research suggests potential for joint ventures or referral partnerships, enabling shared expertise, cross-selling opportunities, and a broader service portfolio for customers in bone research.